Association studies of the adenosine A2a receptor (1976T > C) genetic polymorphism in Parkinson's disease and schizophrenia

Journal of Neural Transmission

Volumn 112, Issue 11, 2005, Pages 1503-1510

  Hong, C J ^a,b   Liu, H C ^b,c   Liu, T Y ^a   Liao, D L ^d   Tsai, S J ^a,b  

^a TAIPEI VETERANS GENERAL HOSPITAL   (Taiwan)

^b NATIONAL YANG MING UNIVERSITY   (Taiwan)

^c Neurological Institute   (Taiwan)

^d Pali Psychiatric Hospital   (Taiwan)

Author keywords

Adenosine A2a receptor; Age at onset; Parkinson's disease; Polymorphism; Schizophrenia; Tardive dyskinesia

Indexed keywords

ADENOSINE A2A RECEPTOR; DOPAMINE 2 RECEPTOR; NEUROLEPTIC AGENT;

ADULT; AGED; ALLELE; ARTICLE; CONTROLLED STUDY; DOPAMINERGIC NERVE CELL; FEMALE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; MOLECULAR GENETICS; MOTOR DYSFUNCTION; NERVE DEGENERATION; NEUROPATHOLOGY; ONSET AGE; PARKINSON DISEASE; POPULATION RESEARCH; PRIORITY JOURNAL; RECEPTOR INTRINSIC ACTIVITY; SCHIZOPHRENIA; TARDIVE DYSKINESIA;

AGE DISTRIBUTION; AGE OF ONSET; AGED; ASIAN CONTINENTAL ANCESTRY GROUP; BASE SEQUENCE; BRAIN; BRAIN CHEMISTRY; CYTOSINE; DNA MUTATIONAL ANALYSIS; DYSKINESIA, DRUG-INDUCED; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC SCREENING; GENOTYPE; HUMANS; MALE; MIDDLE AGED; PARKINSON DISEASE; POINT MUTATION; POLYMORPHISM, GENETIC; RECEPTOR, ADENOSINE A2A; SCHIZOPHRENIA; SEX DISTRIBUTION; TAIWAN; THYMINE;

EID: 27144490664     PISSN: 03009564     EISSN: 14351463     Source Type: Journal    
DOI: 10.1007/s00702-005-0286-4     Document Type: Article

References (29)

1. S Akhondzadeh E Shasavand H Jamilian O Shabestari A Kamalipour 2000 Dipyridamole in the treatment of schizophrenia: adenosine-dopamine receptor interactions. J Clin Pharm Ther 25 131 137
2. K Alsene J Deckert P Sand H de Wit 2003 Association between A2a receptor gene polymorphisms and caffeine-induced anxiety. Neuropsychopharmacology 28 1694 1702
3. W Bara-Jimenez A Sherzai T Dimitrova A Favit F Bibbiani M Gillespie MJ Morris MM Mouradian TN Chase 2003 Adenosine A(2A) receptor antagonist treatment of Parkinson's disease. Neurology 61 293 296
4. AS Bassett EW Chow R Weksberg 2000 Chromosomal abnormalities and schizophrenia. Am J Med Genet 97 45 51
5. F Bibbiani JD Oh JP Petzer N Castagnoli Jr JF Chen MA Schwarzschild TN Chase 2003 A2A antagonist prevents dopamine agonist-induced motor complications in animal models of Parkinson's disease. Exp Neurol 184 285 294
6. J Deckert MM Nothen M Rietschel D Wildenauer B Bondy MA Ertl M Knapp PR Schofield M Albus W Maier P Propping 1996 Human adenosine A2a receptor (A2aAR) gene: systematic mutation screening in patients with schizophrenia. J Neural Transm 103 1447 1455
7. J Deckert MM Nothen P Franke C Delmo J Fritze M Knapp W Maier H Beckmann P Propping 1998 Systematic mutation screening and association study of the A1 and A2a adenosine receptor genes in panic disorder suggest a contribution of the A2a gene to the development of disease. Mol Psychiatry 3 81 85
8. J Deckert M Brenner N Durany R Zochling W Paulus G Ransmayr T Tatschner W Danielczyk K Jellinger P Riederer 2003 Up-regulation of striatal adenosine A(2A) receptors in schizophrenia. Neuroreport 14 313 316
9. S Ferre A Rubio K Fuxe 1991 Stimulation of adenosine A2 receptors induces catalepsy. Neurosci Lett 130 162 164
10. S Ferre WT O'Connor P Snaprud U Ungerstedt K Fuxe 1994a Antagonistic interaction between adenosine A2A receptors and dopamine D2 receptors in the ventral striopallidal system. Implications for the treatment of schizophrenia. Neuroscience 63 765 773
11. S Ferre R Schwarcz XM Li P Snaprud SO Ogren K Fuxe 1994b Chronic haloperidol treatment leads to an increase in the intramembrane interaction between adenosine A2 and dopamine D2 receptors in the neostriatum. Psychopharmacology 116 279 284
12. S Ferre F Ciruela M Canals D Marcellino J Burgueno V Casado J Hillion M Torvinen F Fanelli P Benedetti Pd SR Goldberg M Bouvier K Fuxe LF Agnati C Lluis R Franco A Woods 2004 Adenosine A2A-dopamine D2 receptor-receptor heteromers. Targets for neuro-psychiatric disorders. Parkinsonism Relat Disord 10 265 271
13. S Fredduzzi R Moratalla A Monopoli B Cuellar K Xu E Ongini F Impagnatiello MA Schwarzschild JF Chen 2002 Persistent behavioral sensitization to chronic L-DOPA requires A2A adenosine receptors. J Neurosci 22 1054 1062
14. BB Fredholm P Svenningsson 2003 Adenosine-dopamine interactions: development of a concept and some comments on therapeutic possibilities. Neurology 61 [11 Suppl 6] S5 S9
15. R Guieu B Dussol G Halimi G Bechis F Sampieri Y Berland J Sampol F Couraud H Rochat 1998 Adenosine and the nervous system: pharmacological data and therapeutic perspectives. Gen Pharmacol 31 553 561
16. Guy W (1976) Early clinical drug evaluation unit. Assessment manual for psychopharmacology. Department of Health Education and Welfare, Washington DC
17. SP Hamilton SL Slager AB De Leon GA Heiman DF Klein SE Hodge MM Weissman AJ Fyer JA Knowles 2004 Evidence for genetic linkage between a polymorphism in the adenosine 2A receptor and panic disorder. Neuropsychopharmacology 29 558 565
18. W Hauber P Neuscheler J Nagel CE Muller 2001 Catalepsy induced by a blockade of dopamine D1 or D2 receptors was reversed by a concomitant blockade of adenosine A(2A) receptors in the caudate-putamen of rats. Eur J Neurosci 14 1287 1293
19. J Kulisevsky M Barbanoj A Gironell R Antonijoan M Casas B Pascual-Sedano 2002 A double-blind crossover, placebo-controlled study of the adenosine A2A antagonist theophylline in Parkinson's disease. Clin Neuropharmacol 25 25 31
20. CN Lin HC Liu SJ Tsai TY Liu CJ Hong 2002 Association study for Parkinson's disease and a dopamine transporter gene polymorphism (1215A/G). Eur Neurol 48 207 209
21. PB Lucas D Pickar J Kelsoe M Rapaport C Pato D Hommer 1990 Effects of the acute administration of caffeine in patients with schizophrenia. Biol Psychiatry 28 35 40
22. O Ohmori T Suzuki H Kojima T Shinkai T Terao T Mita K Abe 1998 Tardive dyskinesia and debrisoquine 4-hydroxylase (CYP2D6) genotype in Japanese schizophrenics. Schizophr Res 32 107 113
23. MJ Owen P Holmans P McGuffin 1997 Association studies in psychiatric genetics. Mol Psychiatry 2 270 273
24. B Parsons DM Togasaki S Kassir S Przedborski 1995 Neuroleptics up-regulate adenosine A2a receptors in rat striatum: implications for the mechanism and the treatment of tardive dyskinesia. J Neurochem 65 2057 2064
25. A Pinna J Wardas A Cozzolino M Morelli 1999 Involvement of adenosine A2A receptors in the induction of c-fos expression by clozapine and haloperidol. Neuropsychopharmacology 20 44 51
26. AM Sebastiao JA Ribeiro 2000 Fine-tuning neuromodulation by adenosine. Trends Pharmacol Sci 21 341 346
27. SJ Tsai 2005 Adenosine A2a receptor/dopamine D2 receptor hetero-oligomerization: a hypothesis that may explain behavioral sensitization to psychostimulants and schizophrenia. Med Hypotheses 64 197 200
28. SJ Tsai HC Liu TY Liu CY Cheng CJ Hong 2002 Association analysis for genetic variants of the NMDA receptor 2b subunit (GRIN2B) and Parkinson's disease. J Neural Transm 109 483 488
29. SJ Wang JL Fuh EL Teng CY Liu KP Lin HM Chen CH Lin PN Wang YC Ting HC Wang KN Lin P Chou EB Larson HC Liu 1996 A door-to-door survey of Parkinson's disease in a Chinese population in Kinmen. Arch Neurol 53 66 71